Pharmaceutical effervescent composition of new generation antidepressants

GR1011209BActive Publication Date: 2026-06-04TSETI IOULIA
8 Cites 0 Cited by

Patent Information

Application Number
GR20250100382
Authority / Receiving Office
GR · GR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2025-05-20
Publication Date
2026-06-04
Estimated Expiration
2045-05-20
Patent Text Reader

Abstract

The invention relates to pharmaceutical compositions of antidepressant substances, which compositions are in the form a) effervescent tablets or b) effervescent granules or powder or c) orodispersible tablets, where the antidepressant substance is either i) a selective serotonin reuptake inhibitor (SSRI) chosen among escitalopram, citalopram, sertraline, paroxetine, fluvoxamine, etoperidone or apharmaceutically acceptable form thereof, or ii) a selective serotonin and norepinephrine reuptake inhibitor (SNRI) chosen among duloxetine and venlafaxine or a pharmaceutically acceptable form thereof.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Escitalopram Oxalate Effervescent Tablets: Formula and Preparation Process

    CN105343026B

  • Pharmaceutical composition for treating female climacteric syndrome

    CN111035763A

  • Effervescent citalopram tablets and salts

    GR1005814B

  • Controlled release pharmaceutical compositions for prolonged effect

    US20100239667A1

  • Antidepressant oral pharmaceutical compositions

    US8093408B2